RecruitingPhase 2NCT07047690
Rare condition
Limited systemic sclerosis
5
studies recruiting now
as of 7 Sept 2026
25
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
18 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT07292961
Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma
RecruitingNCT07183072
Patients Diagnosed With Scleroderma: Physical Performance and Functionality
RecruitingNCT07182968
Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
RecruitingNCT07182981
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Limited systemic sclerosis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Limited systemic sclerosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Limited systemic sclerosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (HLA-DRB1).
Treatments being studied
1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Mycophenolate Mofetil (Arzip)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).